Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

pantethine

Known as: D-Bis(N-Pantothenyl-2-Aminoethyl)-Disulfide, bis(N-pantothenylamidoethyl) disulfide 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Pantetheine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Inhibiting extracellular vesicles formation and release: a review of EV inhibitors
ABSTRACT It is now becoming well established that vesicles are released from a broad range of cell types and are involved in cell… 
Highly Cited
2014
Highly Cited
2014
Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model
Pantothenate kinase-associated neurodegeneration, caused by mutations in the PANK2 gene, is an autosomal recessive disorder… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2013
Review
2013
Cell-derived microparticles: new targets in the therapeutic management of disease.
Intercellular communication is essential to maintain vital physiological activities and to regulate the organism's phenotype… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2010
Highly Cited
2010
Pantethine rescues a Drosophila model for pantothenate kinase–associated neurodegeneration
Pantothenate kinase–associated neurodegeneration (PKAN), a progressive neurodegenerative disorder, is associated with impairment… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Highly Cited
2008
Highly Cited
2008
Protection against cerebral malaria by the low-molecular-weight thiol pantethine
We report that administration of the low-molecular-weight thiol pantethine prevented the cerebral syndrome in Plasmodium berghei… 
  • figure 2
  • figure 1
  • figure 3
  • table 1
  • figure 4
Review
2001
Review
2001
Natural therapies for ocular disorders, part two: cataracts and glaucoma.
  • K. Head
  • Alternative medicine review : a journal of…
  • 2001
  • Corpus ID: 936933
Pathophysiological mechanisms of cataract formation include deficient glutathione levels contributing to a faulty antioxidant… 
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
1986
1986
Effect of probucol, pantethine and their combinations on serum lipoprotein metabolism and on the incidence of atheromatous lesions in the rabbit.
Effect of probucol, pantethine and their combinations on serum lipoprotein metabolism and on the incidence of atheromatous… 
Highly Cited
1984
Highly Cited
1984
Controlled evaluation of pantethine, a natural hypolipidemic compound, in patients with different forms of hyperlipoproteinemia.
Pantethine (P), the stable disulphate form of pantetheine, major component and precursor of coenzyme A, was evaluated within a… 
Highly Cited
1970
Highly Cited
1970
The enzymatic breakdown of pantethine to pantothenic acid and cystamine.
The enzyme splitting pantethine into pantothenic acid and cystamine has been purified about 3000 times starting from horse kidney… 
Highly Cited
1951
Highly Cited
1951
THE COMPARATIVE ACTIVITIES OF PANTETHINE, PANTOTHENIC ACID, AND COENZYME A FOR VARIOUS MICROORGANISMS
Several fastidious lactic acid bacteria require a new growth factor, originally termed the Lactobacillus bulgartcu8 factor (LBF… 
  • table 1
  • table 2
  • figure 1
  • figure 8
  • figure 4
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE